Research on HIV infection and how the virus behaves. Covers viral persistence, prevention policy, adolescent consent, and how HIV infects cells.
The University of Pittsburgh-affiliated Magee-Womens Research Institute has been selected to lead international HIV/AIDS prevention and treatment efforts. The institute will focus on developing microbicides to prevent HIV transmission, particularly among women and their partners.
Researchers at the University of Montreal have identified defective immune cells as a primary cause of fungal infections, such as candidiasis, in HIV patients. This discovery could lead to more effective treatments for these debilitating conditions.
University of Rochester experts discuss how flu invades and responds to the body, with a focus on understanding its pathogenesis. The research aims to prevent potential modification of the flu virus for lethal use and develop more effective treatments.
A new international collaboration aims to identify genetic variations that affect the body's response to HIV. By analyzing patient cohorts from nine countries, researchers hope to pinpoint common genes influencing the disease progression and develop a vaccine targeting these responses.
A study found that HIV-positive mothers-to-be are at a higher risk of developing anaemia, pregnancy-induced hypertension, and other health issues. Women with HIV also received less antenatal care and experienced lower birth weights, highlighting the need for better guidance on managing pregnant women with HIV.
Researchers found that a viral protein helps monkeys resist AIDS symptoms, but HIV-1 lacks this protective function, leading to increased immune activation and disease progression. The study suggests that treatments mimicking the primate immune system might offer a new approach to HIV therapy.
Researchers found that monkeys vaccinated against simian immunodeficiency virus (SIV) survived longer after infection compared to unvaccinated animals. The vaccine regimen preserved memory CD4+ T cells, enabling the animals to live healthier lives.
Researchers at Harvard Medical School have made significant progress in understanding the efficacy of an AIDS vaccine. The study found that vaccines can control HIV infection for approximately 100 days, followed by nearly three years, with vaccinated monkeys living significantly longer than unvaccinated ones.
The IU School of Medicine has received a $8.9 million grant to expand its HIV/AIDS programs in Kenya. The program, AMPATH, will provide anti-retroviral drug treatments to over 18,000 people by September 2007 and screen more than 25,000 pregnant women annually.
The HBZ protein is crucial for persistent infection of HTLV-1 in an animal host. Researchers discovered that a drug targeting this protein could disrupt viral replication and provide a new therapy for infected individuals.
A new study found that HIV infection rates among young non-Hispanic blacks are significantly higher than other racial groups, with a rate of 4.9 per 1,000 compared to 0.22 for all other races. The study suggests that segregation and differences in sexual networks contribute to the disparity.
Advances in HIV care have yielded a total survival benefit of 2.8 million years in the US, saving an additional 137,000 years of life through mother-to-child transmission prevention. The study found that HIV therapies have transformed the disease from a rapidly fatal condition to a controllable one.
A new study analyzed national surveillance data and found that widespread adoption of highly active antiretroviral therapy (HAART) led to at least 3 million years of life saved in the US. The study suggests that reducing barriers to care, such as pre-test counseling, could lead to even greater benefits.
The Infectious Diseases Society of America calls for routine HIV testing to identify those who need treatment. Early testing and connection with care can save millions more lives beyond the three million already saved through antiretroviral therapy.
A cell biology study has identified distinct signaling pathways between neurokinin-1 receptors and substance P, which could be used to block HIV entry into macrophages. The findings also highlight the potential of a drug called aprepitant as an HIV treatment.
A recent study highlights the importance of HIV testing for pregnant women, as even with treatment, an infected mother still poses a 25% risk of infecting her child. The use of rapid testing can significantly reduce this risk, but many women lack access to these tests due to lack of proof or electronic medical records issues.
Dendritic cells are specialized white blood cells that patrol the body for infections. The new discovery reveals they have a highly organized structure, acting as specialized squads to deal with specific problems. This breakthrough sheds light on their role in preventing autoimmune diseases and could lead to new immune therapies.
Researchers from University of North Carolina Health Care and N.C. State University develop a vaccine that protects animals from chancroid, a sexually transmitted disease that can enhance HIV transmission. The study suggests that a chancroid vaccine could be relatively easy to develop and may help reduce HIV transmission in Africa.
A new international study led by Dr. Myron S. Cohen at the University of North Carolina Health Care is investigating the early biology of HIV infection to develop an effective vaccine. The study, known as CHAVI-001, aims to identify people with HIV in its earliest stages and track their health to determine the transmission pairs.
Researchers developed a peptide, D6R, that blocks lethal toxins of anthrax by inhibiting furin activity. The peptide has shown promising therapeutic potential against various bacterial infections, including Pseudomonas aeruginosa and Ebola, without invoking a cytokine response.
A new study will develop a cohort of 1,000 HIV-infected IDUs with a history of injection drug use to examine treatment access and adherence. The research aims to improve access to life-saving HIV and HCV treatments for marginalized individuals in Vancouver's Downtown Eastside.
Researchers found increased expression of immune response genes, including CCL5, in the brain, which may contribute to neurodegenerative symptoms and cognitive dysfunction in HIV-infected individuals. The study provides insights into the chronic phase of NeuroAIDS, a significant health problem affecting quality of life.
A mathematical model reveals that implementing isoniazid preventive therapy (IPT) in co-infected individuals may increase the transmission of drug-resistant TB. Large-scale IPT programs need to be equipped to diagnose and treat resistant cases as part of their strategy.
A study assessing combined interventions found co-trimoxazole, ART, and insecticide-treated bed nets substantially reduced malaria frequency in HIV-infected adults. The treatments had a cumulative protective effect on malaria incidence, with co-trimoxazole lowering rates by 76%, ART and co-trimoxazole by 92%, and all three by 95%.
Researchers identify matrix protein as critical component in VSV's ability to invade cells and replicate, leading to potential vaccine development and anti-viral agents. The discovery also provides insights into how viruses shut down cell protein-making capabilities.
A new study by Johns Hopkins Medicine researchers suggests that a commercially available antibiotic, ceftriaxone, may be effective in fighting dementia in HIV patients. The study found that ceftriaxone protected human neuronal cells from the effects of HIV proteins Tat and gp120.
Researchers at Rice University propose a novel approach to combat Dengue virus by administering multiple vaccines simultaneously at different locations on the body, bypassing immunodominance and enhancing immunity against all four closely related viruses. This strategy has implications for other diseases such as HIV and cancer.
A University of Toronto study found HIV infection rates declining in South India, likely due to increased condom use and awareness programs. The study tracked data from antenatal clinics, showing a significant decrease in new infections among young adults.
TB researchers hope to find novel ways of killing the organism using a protective protein called heme oxygenase 1. The project aims to pinpoint the role of alcoholism in the global epidemic by studying HIV- and tuberculosis-infected patients in India.
A study published in Archives of Dermatology found that injecting polylactic acid can safely and effectively treat facial lipoatrophy in HIV patients, improving skin and fat thickness over 12 months. The treatment showed significant results, with increased dermal thickness persisting beyond the initial six injections.
A new model by Imperial College London researchers suggests that anti-HIV drugs alone are unlikely to stop the spread of HIV and may even increase infection rates due to improved health and behavior, highlighting the importance of prevention initiatives.
A study suggests that increasing access to antiretroviral therapy (ART) in resource-poor countries may not reduce HIV infection rates, but rather increase transmission due to prolonged survival and increased sexual activity. Counseling patients and promoting safe sex practices are crucial in preventing the spread of the virus.
Two DNA repair proteins, XPB and XPD, can destroy HIV DNA, reducing viral replication and integration into host chromosomes. This finding may lead to new strategies for treating HIV infection and AIDS.
Researchers found that cytotoxic T lymphocytes (CTLs) kill only a fraction of infected cells, with most deaths attributed to other factors. The study suggests that CTL-based vaccines may not prevent or clear HIV infection and could control the number of infected cells instead.
Researchers at HHMI used molecular dynamics simulations to identify a potential new drug target for treating HIV, which is often resistant to existing medications. The study focused on a rare strain of HIV with mutations that can evade commonly prescribed drugs.
A new study found that early antiretroviral therapy can significantly improve CD4 cell count outcomes in HIV-infected infants. Children who started treatment between 5 months and 5 years of age were 60% less likely to experience a decline in their CD4 cell count z-score compared to those who started treatment before 5 months.
Researchers at U of MN found that a diverse inventory of T-cells is essential for optimal immune function. They developed a method to monitor small numbers of specific T-cells in mice, revealing that these cells survive and activate more effectively in normal quantities.
The worldwide state of tuberculosis epidemiology, diagnosis, and treatment is examined through research results published in 2005. TB remains a top cause of HIV-related mortality in sub-Saharan Africa, with high incidence rates among gold miners and those with recent M. tuberculosis infection.
A new study suggests that Tijuana's HIV infection rate may be close to three times higher than Mexico's national average, posing a significant public health threat. The researchers emphasize the need for urgent intervention and prevention strategies targeting high-risk groups.
A new study published in AIDS and Behavior found that pregnancy, rather than high-risk behavior, was the primary predictor of STD testing among newly homeless youth. The study, conducted at UCLA, surveyed 261 homeless youth aged 12-20 and found a 32% STD rate among those who had received an STD test in the past three months.
A new study suggests that a vaginal gel containing the antiretroviral drug tenofovir may be effective in preventing HIV transmission in women. The gel produced mild or no side effects in both HIV-positive and negative women, but further studies are needed to evaluate its effectiveness.
A review of 12,000 Ugandan women found that male circumcision significantly reduced the likelihood of HIV infection among female partners. The study also found a reduction in other STDs, such as human papillomavirus and syphilis, but not gonorrhea or Chlamydia.
A study found that HIV subtype D is associated with a higher risk of early death from AIDS compared to subtype A. The researchers analyzed data from over 300 newly infected individuals in Uganda and found that those infected with subtype D had a significantly shorter average survival time.
Researchers found a significant decline in HIV prevalence in some groups, with a 49% drop for women aged 15-24 and a 23% drop for men aged 17-29. Behavioral changes, including delayed sex and fewer casual partners, are believed to be the main reason for this decline.
A Duke University Medical Center study found that free HIV tests are more cost-effective in preventing infections, drawing in three times as many people for testing. The research showed that the cost of prevention dropped from $170 to $92 per person when testing rates increased.
Research on women with HIV found that those infected with both HIV and high-risk HPV were at greatest risk of developing cervical cancer precursors. A study on postmenopausal women found sex hormone levels to be not associated with breast cancer risk, while another study suggested that BRCA2 mutation carriers had a fourfold increased i...
Researchers found a link between CCR5 mutation and increased risk of severe West Nile virus infection. Individuals with this mutation had higher rates of symptomatic cases, highlighting potential implications for HIV treatment.
U.S. researchers have developed a new vaccine candidate against hepatitis C using dendritic cells, which reduced the amount of carrier virus expressing HCV protein in mice by 100,000 times compared to controls. The study's findings offer a promising approach to prevent liver disease and eliminate the virus from the body.
A genetic mutation, CCR5delta32, makes individuals more susceptible to West Nile virus infections. Research suggests that this lack of a protein can prevent protective immune cells from reaching the brain, increasing the risk of severe disease.
Researchers have discovered a novel strategy for enhancing HIV vaccination by silencing the SOCS1 molecule in dendritic cells, which can induce a good memory immune response and boost the potency of HIV DNA vaccination. This approach has potential for therapeutic and prophylactic vaccines against HIV and other pathogens.
A new HIV vaccine strategy involves removing the natural immune system's 'brake' to enhance anti-HIV responses, showing promise for improved treatment and prevention. The approach uses a molecule called SOCS1 to regulate immune cells and boost antibody and T-cell responses.
Researchers have discovered a gene, PD-1, that causes CD8 T cells to become exhausted in mice with chronic viral infections. By blocking the PD-1/PD-L1 bond, they reactivated the cells' response to infection and reduced viral load.
Researchers at SLU have made a groundbreaking discovery on the molecular mechanism of HIV integration, shedding light on how the virus invades healthy cells. The study reveals that integrase holds viral DNA together prior to integration, paving the way for new drug therapy options.
Researchers have found that Sangamo's ZFN-modified cells are resistant to HIV infection, whereas control cells are infected. The treatment works by disrupting the CCR5 gene, a receptor required for HIV entry into immune cells. This approach has advantages over other drugs in development, which require constant antagonist presence.
Researchers found that identical twins infected with the same HIV strain had different T-cell receptor characteristics, indicating a random and unpredictable immune response. This discovery challenges the idea of developing a single, universal vaccine for everyone.
Researchers are developing new methods for immunization, including transdermal and nasal delivery, which could prevent needle-caused infections and reduce economic burdens. Interdisciplinary efforts are underway to make needle-free immunizations a common practice.
A study of British adults found the rate of paid-for sex with women has more than doubled between 1990 and 2000. Men who paid for sex were more likely to be younger, single, and from London, and had had multiple sexual partners
A study of over 3,900 children with HIV found that total lymphocyte count can predict disease progression as well as CD4 cell percentage. The current WHO guidelines for starting ART are inconsistent and may lead to inadequate treatment in low-income countries.
A study by William Moss and colleagues found that zinc supplementation did not increase blood HIV viral load but reduced diarrhoea in children with HIV-infection. The authors suggest using zinc as an adjunct therapy to reduce morbidity and mortality in resource-poor countries.
Researchers discovered cross-reactive T cells in patients with infectious mononucleosis, which stimulated excessive lymphocyte proliferation. Meanwhile, selectively killing regulatory T cells improved the efficacy of cancer vaccines by enhancing tumor-specific T cell responses.